graphic
graphic  
graphic
News
graphic
Celera trims 1Q loss
graphic October 24, 2001: 7:51 a.m. ET

Gene mapping firm cuts shortfall on increase in revenue.
graphic
graphic graphic
graphic
NEW YORK (CNNmoney) - Celera Genomics Group, one of the firms to successfully map the human gene sequence, posted a narrower fiscal first-quarter loss than anticipated Wednesday as higher sales and lower research and development expenses helped the company pare its losses.

Rockville, Md.-based Celera posted a loss of $15.6 million, or 25 cents per share, down from a loss of $25.7 million, or 43 cents per share, a year earlier. Analysts expected the company to lose 46 cents per share, according to earnings tracker First Call.

Revenue rose to $27.3 million from $18.3 million in the year-earlier quarter.

graphic  
Celera said the quarter included a pretax loss of $9.4 million for its interest in a joint venture with Applied Biosystems.

In addition, Celera said it expects 40 percent to 50 percent revenue growth in 2002.

Analysts expect the company to lose 48 cents per share in its second quarter ending Dec. 31, according to First Call.

Shares of Celera (CRA: Research, Estimates) fell 50 cents Tuesday to $25.90. graphic





graphic graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.
graphic